EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Overview of approved and upcoming vaccines for SARS-CoV-2: a living review

Jennifer Alderson iD, Vicky Batchelor, Miriam O'Hanlon, Liliana Cifuentes, Felix Clemens Richter, Jakub Kopycinski, Oxford-Cardiff COVID-19 Literature Consortium

Oxford Open Immunology · 2021

DOI: 10.1093/oxfimm/iqab010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oxford Open Immunology, 2021. Verfasst von Jennifer Alderson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr…. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centre for Osteoarthritis Pathogenesis Versus Arthritis, Centre for Sport, Exercise and Osteoarthritis Research Versus Arthritis, FOREUM.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rapid design and implementation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines is testament to a successfully coordinated global research effort. While employing a variety of different technologies, some of which have been used for the first time, all approved vaccines demonstrate high levels of efficacy with excellent safety profiles. Despite this, there remains an urgent global demand for coronavirus disease 2019 vaccines that require further candidates to pass phase 3 clinical trials. In the expectation of SARS-CoV-2 becoming endemic, researchers are looking to adjust the vaccine constructs to tackle emerging variants. In this review, we outline different platforms used for approved vaccines and summarize latest research data with regards to immunogenicity, dosing regimens and efficiency against emerging variants.

Schlagwörter

Stichwörter der Autor:innen

SARS-CoV-2effectivenessefficacyvaccinevariant

Autor:innen und Institutionen

  • Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Drive, Headington, OX3 7FY Oxford, UK.
  • Nuffield Department of Medicine, University of Oxford, Old Road Campus, Roosevelt Drive, Headington, OX3 7FZ Oxford, UK.

ORCID-Profile: Jennifer Alderson

Förderung

  • Centre for Osteoarthritis Pathogenesis Versus Arthritis
  • Centre for Sport, Exercise and Osteoarthritis Research Versus Arthritis
  • FOREUM
  • Centre for OA Pathogenesis Versus Arthritis
  • Cancer Research UK
  • Oxford-Bristol Myers Squibb Fellowship
  • Infection, Immunology and Translational Medicine Wellcome Trust Studentship

Zitieren

APA

Alderson, J., Batchelor, V., O'Hanlon, M., Cifuentes, L., Richter, F. C., Kopycinski, J., & Oxford-Cardiff COVID-19 Literature Consortium (2021). Overview of approved and upcoming vaccines for SARS-CoV-2: a living review. Oxford Open Immunology. https://doi.org/10.1093/oxfimm/iqab010

Vancouver

Alderson J, Batchelor V, O'Hanlon M, Cifuentes L, Richter FC, Kopycinski J, et al. Overview of approved and upcoming vaccines for SARS-CoV-2: a living review. Oxford Open Immunology. 2021. doi:10.1093/oxfimm/iqab010

BibTeX
@article{Alderson2021,
  author = {Alderson, Jennifer and Batchelor, Vicky and O'Hanlon, Miriam and Cifuentes, Liliana and Richter, Felix Clemens and Kopycinski, Jakub and Oxford-Cardiff COVID-19 Literature Consortium, Oxford-Cardiff COVID-19 Literature Consortium},
  title = {Overview of approved and upcoming vaccines for SARS-CoV-2: a living review},
  journal = {Oxford Open Immunology},
  year = {2021},
  doi = {10.1093/oxfimm/iqab010}
}
Kostenlos starten →